Multivariate analysis demonstrated that miR-184, miR-146b, miR-509-3 and LPAR5 were an independent risk factors for prognosis, and they have the potential to be the targets for treatment of thyroid cancer. This evidence concerns the gene LPAR5 and thyroid gland carcinoma.